FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics

The Subcommittee on Health of the Committee on Energy and Commerce will hold a hybrid hearing that includes both in-person and remote attendance on Thursday, February 3, 2022, at 10:30 a.m. This hearing will take place in the John D. Dingell Room, 2123 of the Rayburn House Office Buidling, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics."

Legislation

H.R.____, the "Biosimilar User Fee Amendments of 2022"

H.R.____, the"Generic Drug User Fee Amendments of 2022"

H.R.____, the "Prescription Drug User Fee Amendments of 2022"

https://energycommerce.house.gov/committee-activity/hearings/hearing-on-fda-user-fee-reauthorization-ensuring-safe-and-effective